Evaluation of antigen-induced synovitis in a porcine model: immunological, arthroscopic and kinetic studies by Vela González, Francisco Javier et al.
RESEARCH ARTICLE Open Access
Evaluation of antigen-induced synovitis in a
porcine model: Immunological,
arthroscopic and kinetic studies
Francisco-Javier Vela1†, Francisco-Miguel Sánchez-Margallo1,5†, Rebeca Blázquez1,5*, Verónica Álvarez1,
Raquel Tarazona2, M. Teresa Mangas-Ballester3, Alejandro Cristo4 and Javier G. Casado1,2,5
Abstract
Background: Synovitis is an inflammation-related disease linked to rheumatoid arthritis, osteoarthritis, infections
and trauma. This inflammation is accompanied by immune cells infiltration which initiates an inflammatory
response causing pain, discomfort and affecting the normal joint function. The treatment of synovitis is based on
the administration of anti-inflammatory drugs or biological agents such as platelet rich plasma and mesenchymal
stem cells. However, the evaluation and validation of more effective therapies of synovitis requires the
establishment of clinically relevant animal models.
Results: In this study, Large White pigs were pre-immunized to evaluate an antigen-induced synovitis. The immune
monitoring of synovial fluids in this model allowed us the identification of IL-12p40 and T cell subsets as immune
biomarkers. Moreover, the evolution of synovitis was performed by arthroscopic procedures and kinetic analysis.
In summary, this paper describes an animal model of antigen-induced synovitis to be used in the evaluation of
anti-inflammatory therapies.
Conclusions: The novelty of this paper lies in the development of a clinically relevant model of synovitis which
permits the simultaneous evaluation of synovitis from an immunological, surgical and kinetic point of view.
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Background
The synovial fluid (SF) is a transudate of plasma that
provides low-friction for a normal joint function [1]. The
homeostasis of SF depends on the continuous renewal
from the lymphatic capillaries to the articular cavity and
the transynovial filtration towards the lymphatic capillaries.
This renewal is also facilitated by physical exercise and
joint flexion [2]. The synovitis is an inflammation-related
disease usually linked to rheumatoid arthritis [3], osteo-
arthritis [4, 5] and viral infections [6]. The inflammation of
synovial tissue is accompanied to immune cells infiltration
(mainly composed by macrophages and T and B lympho-
cytes) which initiates an inflammatory response causing
pain and discomfort [7] and affecting the normal joint
function [8].
At the present, some of the most common treatments
for synovitis are based on the administration of non-
steroidal anti-inflammatory drugs [9] as well as biological
agents such as platelet rich plasma [10], autologous condi-
tioned medium [11] and mesenchymal stem cells isolated
from different sources [12] that have become a promising
therapeutic option in regenerative medicine due to their
self-renewal capacity, multipotentiality and immunomo-
dulatory properties [13, 14].
Similarly to other diseases, the development of more
effective therapies for the treatment of synovitis requires
the establishment of clinically relevant animal models.
Ideally, a valuable animal model for this inflammatory-
related disease should be suitable for the evaluation of
immune biomarkers and kinematic parameters. At the
present, several animal models of synovitis have been
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described including dogs [15], rats [16] and rabbits [17].
However, due to their translational applicability, other
large animal models such as pigs or sheep have been
considered as the more appropriate models for this kind
of studies [18]. Concretely, the morphological and
physiological similarities of pigs and humans in terms of
cartilage thickness, biomechanical features and joint
dimensions become this animal model particularly
attractive for further clinical translation.
Based on that, the aim of this work was to develop
and characterize a clinically relevant large animal model
of synovitis. The novelty of this manuscript lies in the
development of an animal model which permits to
researchers the evaluation, monitoring and follow up of
synovitis from different perspectives: firstly, from an
immunological point of view through the evaluation of
immunological biomarkers (synovial fluid lymphocytes
and IL-12p40), and secondly, from a biomechanical and
surgical point of view by arthroscopic and kinetic gait
analysis.
Methods
Animals and experimental design
Eight Large White pigs were housed in the animal facility
at the Minimally Invasive Surgery Centre and used for all
experimental procedures. Animals aged 3 months and
weighed 25–35 kg at the beginning of the study were used.
All experimental protocols were approved by the Commit-
tee on the Ethics of Animal Experiments of Minimally
Invasive Surgery Centre and fully complied with recom-
mendations outlined by the local government (Junta de
Extremadura) and by the Directive 2010/63/EU of the
European Parliament on the protection of animals used
for scientific purposes.
All the animals were pre-immunized by subcutaneous
injections of bovine serum albumin (BSA). Local immu-
nizations for synovitis induction were performed by
intra-articular injection of BSA on the right carpal joint
of each animal. The left carpal joints received an intra-
articular injection of phosphate buffer saline (PBS) to be
used as negative control.
As an additional control group, three Large White pigs
without BSA pre-immunization were included in this
study. Intra-articular injections of PBS and BSA were
performed in the left and the right carpal joints
respectively.
Anesthetics procedures
Every procedure was done under anesthesia. For blood
sampling and subcutaneous BSA injections, anesthesia
was induced by intramuscular injection of 10 mg/kg
ketamine hydrochloride and 0.02 mg/kg dexmedetomi-
dine hydrochloride. The animals were recovered with
0.02 mg/kg atipamezole hydrochloride. For SF sampling
and arthroscopies, anesthesia was induced by the same
procedure together with 2 mg/kg propofol on intraven-
ous bolus injection, and the analgesia was performed
with 3 mg/kg of tramadol. According to ethical and
animal welfare concerns, all the animals received anal-
gesic treatment with buprenorphine hydrochloride. The
buprenorphine at 0.3 mg/ml was regularly administered
at 0.03 ml/kg for 7 days after intra-articular injection.
Immunization protocol
For animal immunizations, a solution with 20 mg/ml of
BSA (Sigma-Aldrich, St. Louis, MO, USA) was prepared
and passed through a 0.2 μm sterilized microfilter. An
equal volume of Freund Complete Adjuvant (FCA)
(Sigma-Aldrich, St. Louis, MO, USA) was mixed with
the BSA solution and emulsified. The immunization was
performed by subcutaneous injection of this emulsion. A
total of 0.4 ml/kg was injected on days 0, 14 and 21 (see
Fig. 1). On day 28, a total of 0.5 ml of SF was aspirated
from both joints (SF basal sample) and intra-articular
immunizations of BSA were performed in the forelimbs.
A total of 0.5 ml of BSA at 20 mg/ml was injected on
the right carpal joint to induce the synovitis and 0.5 ml
PBS on the left carpal joint (used as negative control).
Isolation and phenotypic characterization of synovial fluid
and peripheral blood lymphocytes
Synovial fluid leukocytes (SFLs) were obtained from
carpal joints. A total of 0.5–1 ml of SF was aspirated and
weekly sampled for 5 weeks (see Fig. 1). Leukocytes were
counted in an automatic hematology analyzer (Mindray
BC-5300 Vet, Hamburg, Germany) and SFLs were
isolated by centrifugation at 900×g and used for flow
cytometric analysis. Supernatants were also collected
and stored at −20 °C for cytokines determination.
Peripheral blood lymphocytes (PBLs) were obtained
from jugular vein blood samples. Blood sampling was
performed weekly from the beginning of the study. PBLs
were isolated by centrifugation over Histopaque-1077
(Sigma-Aldrich) and washed twice with PBS for cyto-
metric analysis.
For flow cytometric analysis, PBLs and SFLs were
suspended in PBS containing 2% FBS. The cells were
then stained with PerCP-conjugated monoclonal anti-
body against porcine CD4 (Mouse Anti-Pig CD4a, clone:
74–12-4, BD Pharmingen, San Jose, CA, USA) and
APC-conjugated monoclonal antibody against porcine
CD8 (Mouse Anti-Pig CD8a, clone: 76–2-11, BD
Pharmingen). The cytometric analysis was performed as
follows: 2 × 105 cells were incubated for 30 min at 4 °C
with appropriate concentrations of monoclonal anti-
bodies. The cells were washed and resuspended in PBS.
The flow cytometric analysis was performed in a FACS-
calibur cytometer (BD Biosciences) after acquisition of
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105 events. Cells were primarily selected using forward
and side scatter characteristics and fluorescence was
analyzed using CellQuest software (BD Biosciences, San
Jose, CA, USA). Isotype-matched negative control anti-
bodies were used in all the experiments.
Quantification of anti-BSA antibodies by ELISA
In order to quantify the anti-BSA IgG titers on immu-
nized animals, an ELISA test was performed on plasma
samples. Microplate coating was performed by an over-
night incubation with BSA at 20 μg/ml. The next day,
coating solution was removed and wells were washed
twice with 200 μl of PBS/Tween-20 (0.05%, 7.4 pH). In
order to prevent the nonspecific binding of the anti-
bodies, the remaining protein-binding sites were blocked
by adding 200 μl of BSA and the plate was incubated for
2 h at 4 °C. The plate was washed four times with 200 μl
PBS/Tween-20. Plasma samples were diluted on PBS at
1/200 and 100 μl of this dilution was added to each well.
The plate was incubated for 2 h at 4 °C. After washing
four times with PBS/Tween-20, 100 μl of 1/5000 diluted
horseradish peroxidase (HRP) -conjugated secondary
antibody (Rabbit Anti-Pig IgG, Thermo Fisher Scientific,
Waltham, MA, USA) were added to each well and the
plate was incubated for 2 h at 4 °C. Again, the plate was
washed four times and 100 μl of the enzyme substrate
(3,3′, 5,5′-Tetramethylbenzidineor TMB, Sigma-Aldrich)
were added to each well. Two minutes later, 100 μl of
1 N HCl were added per well in order to stop the reac-
tion. Plate absorbance was measured at 450 nm on a
Synergy Mx spectrophotometer (BioTech Industries,
Newton, NC, USA).
Cytokine detection and measurement with multiplex
technology
The supernatants of SF were diluted 1:4 in PBS and
stored at −20 °C. These supernatants were thawed and
IFNα, IFNγ, IL-1b, IL-4, IL-6, IL-8, IL-10, IL-12p40 and
TNFα were analyzed using a multiplexed immunoassay.
The measurements were performed according to the
manufacturer’s instructions by Luminex xMAP technol-
ogy using the ProcartaPlex Porcine Cytokine & Chemo-
kine Panel 1 (eBioscience, San Diego, CA, USA; catalog
number EPX090–60829-901). The concentrations of the
different cytokines were expressed as pg/ml, and calcu-
lated according to a standard curve.
Arthroscopies
In order to evaluate the potential changes on the joint
status, arthroscopies were performed in the carpal joints
of pre-immunized animals at two weeks after intra-
articular PBS or BSA injection. The arthroscope used on
surgical procedures was a HOPKINS® wide angle
forward-oblique telescope 30°, 2.4 mm diameter, 10 cm
length (Karl Storz, Tuttlingen, Germany).
A needle was used as a guide for the correct placement
of the arthroscope through a small incision. A saline flux
through the joint was maintained during all the procedure
to provide a better visualization of the tissues. A careful
and detailed evaluation of the joint was performed and
photo recorded. Finally, the 3 mm incision was closed
with a 2–0 absorbable suture and every animal received
antibiotic treatment (clavulanic acid + amoxicillin) during
7 days after arthroscopy.
Pressure platform gait analysis functional evaluation by
biomechanical analysis
A 174.5 cm × 36.9 cm pressure platform (PP) (Walkway™;
Tekscan, South Boston, MA, USA), composed by individ-
ual sensors with a density of 1.4 sensor/cm2 and 9152 sen-
sors in total, was used for the biomechanical evaluation.
The sensors of the PP walkway were calibrated according
to the manufacturer’s specifications. Seven days after
intra-articular injection, animals were guided to walk
along the PP and after at least 5 complete passes per ani-
mal, data were analyzed. Impulse (kg x sec) and vertical
Fig. 1 Temporal scheme of the immunization protocol and monitoring. Subcutaneous BSA injections (black arrows), intra-articular BSA injection
(grey arrow), blood sampling (triangles), synovial fluid sampling (squares), pressure platform gait analysis (rhombus) and the arthroscopic surgery
(circle) are shown
Vela et al. BMC Veterinary Research  (2017) 13:93 Page 3 of 10
maximum force (kg) were determined. Measurements
were normalized to animal weights.
Statistical analysis
Data were statistically analyzed using the non-parametric
Man Whitney U-test for paired comparisons and Kruskal-
Wallis test for multiple comparisons. The p-values ≤0.05
were considered statistically significant. All the statistical
determinations were made using SPSS-21 software (SPSS,
Chicago, IL, USA).
Results
The BSA-immunization protocol elicits an antibody and
T cell response on porcine model
The animals were subcutaneously immunized with an
emulsion of BSA and FCA on days 0, 14 and 21. During
the immunization protocol, peripheral blood was weekly
collected from vein and analyzed by flow cytometry to
evaluate the percentage of CD4 + T cells, CD8+ T cells
and their ratio. It is important to note that anti-CD4 and
anti-CD8 antibodies were simultaneously used for the
quantification of CD4+/CD8- and CD4−/CD8+ subsets.
The presence of anti-BSA antibodies in plasma samples
was also quantified by ELISA test.
The analysis of peripheral blood lymphocytes from
BSA-immunized animals demonstrated that the CD8 + T
cell subset showed a trend to increase (non-statistically
significant) whereas both CD4 + T cell subset and CD4/
CD8 ratio showed a trend to decrease (Fig. 2).
Regarding the evaluation of antibodies in plasma sam-
ples, our results demonstrated that anti-BSA IgG antibody
titers were detected in all of the four animals. The
antibody concentrations significantly increased when
compared 7 and 14 days and remained stable from days
14 to 35 showing a maximum level at 4 weeks (Fig. 3).
Based on these immunoassays, here we demonstrate
that BSA-immunization protocol triggered the pre-
sensitization of this animal model, which is prerequisite
to generate an antigen-induced synovitis.
Intra-articular administration of BSA on pre-immunized
animals modifies the leukocyte counts and synovial
lymphocytes distribution
The pre-sensitized animals (subcutaneously immunized
with BSA at day 0, 14 and 21) received an intra-articular
injection of PBS or BSA in left or right carpal joints,
respectively, at day 28. Basal samples were aspirated at
day 28 prior to PBS or BSA injections. Synovial fluids
were aspirated at days 35, 42, 49 and 56 (Fig. 1). The
synovial fluids were centrifuged and synovial leukocytes
were processed for flow cytometry analysis. Non-cellular
fraction of synovial fluid was frozen for subsequent cyto-
kine analyses.
The counting of leukocytes from synovial fluid samples
demonstrated that, at day 35 (7 days post intra-articular
BSA), the leukocyte counts were significantly increased
(p = 0.04) in those carpal joints where BSA was intra-
articularly injected: 0.75 ± 1.12 × 106 /ml in control
samples vs 2.40 ± 1.19 × 106/ml in BSA-injected.
Moreover, the lymphoid and myeloid synovial cells
were quantified in an automatic hematology analyzer.
The distribution of lymphoid/myeloid cells in control
samples was: 67.95 ± 6.57 (% of lymphoid cells) and
32.05 ± 8.11 (% of myeloid cells). On the other hand,
the distribution of lymphoid/myeloid cells after intra-
Fig. 2 Lymphocyte subsets distribution in peripheral blood cells
from BSA-immunized animals. Peripheral blood lymphocytes were
weekly collected for flow cytometry analysis. Black arrows indicate
the subcutaneous BSA injections and the grey arrow indicates the
intra-articular injection. The graphic shows the percentage of CD4+
T cells, CD8+ T cells and their ratio. The lower boundary of the box
indicates the 25th percentile and the upper boundary the 75th-
percentile. Bars above and below the box indicate the 90th and 10th
percentiles. The line within the box marks the median (n = 4). No
statistically significant differences were found between groups
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articular BSA injections was: 40.9 ± 19.93 (% of
lymphoid cells) and 59.1 ± 20.79 (% of myeloid cells).
Once demonstrated that leukocyte counts were signifi-
cantly increased, the analysis of synovial lymphocytes
CD4 + T cells, CD8 + T cells and their ratio was
performed at day 7, 14 and 21 after intra-articular BSA
or PBS injections. Our results did not show any signifi-
cant difference at days 14 and 21 (data not shown). In
contrast, significant differences were observed when syn-
ovial lymphocytes were quantified at day 7 after intra-
articular BSA injections (Fig. 4). As shown in Fig. 4, the
intra-articular administration of BSA on pre-immunized
animals exerted a significant decrease of synovial CD8 + T
cells when compared to basal values (p = 0.025). In con-
trast, the percentage of CD4 + T cells as well as the CD4/
CD8 ratio was significantly increased (p = 0.025 and
p = 0.026, respectively). It is important to note that, in
order to have a control for intra-articular injections, PBS
was intra-articularly injected in pre-sensitized animals
and no significant differences were observed when
compared to basal values (Fig. 4). Moreover, in order
to establish a proper negative control, PBS and BSA
were intra-articularly injected in non-immunized
animals. No differences were observed in terms of CD4 + T
cells, CD8 + T cells, CD4/CD8 ratio (Additional file 1)
and biochemical parameters (Additional file 2).
Altogether, our results demonstrated that intra-articular
administration of BSA on pre-immunized animals elicited
a significant increase of synovial leukocytes as well as a
redistribution of synovial T cell subsets towards a CD4-
driven response.
Local administration of BSA on pre-sensitized animals
modifies the cytokine profile of synovial fluid
Once evaluated the changes in the leukocyte counts as
well as in the percentages of synovial CD4+ and CD8+
T cells, we aimed to evaluate the inflammatory environ-
ment by quantifying a wide range of cytokines. The
following cytokines were quantified by Luminex technol-
ogy: IFNα, IFNγ, IL-1b, IL-4, IL-6, IL-8, IL-10, IL-12p40
and TNFα.
The synovial fluids from immunized animals only
showed detectable and significant differences on IL-12p40
cytokine (data not shown for the rest of cytokines). This
cytokine was quantified at days 7, 14 and 21 after intra-
articular BSA injections.
Our results showed significant differences on IL-12p40
at day 7 after intra-articular BSA-immunization (p ≤ 0.05)
and non-significant differences (but a trend to increase)
were found at day 14. Finally, non-significant differences
were observed after 21 days (Fig. 5).
Arthroscopy as a diagnostic procedure in synovitis
Carpal joints from BSA-immunized animals were evalu-
ated by minimally invasive procedures. Arthroscopy was
performed at day 14 after intra-articular BSA or PBS
injections. A total of 8 arthroscopic evaluations were
performed and four out of four carpal joints where BSA
was intra-articularly injected showed a slightly red to
orange color (Fig. 6d). In contrast, those control carpal
joints where PBS was injected, showed clear, colorless or
straw colored synovia (Fig. 6c).
Apart from the macroscopic observation, aspirated
synovial fluids from control and BSA were classified
according to synovial nucleated cells. This classification
Fig. 3 Humoral response to bovine serum albumin in immunized
animals. Plasma samples were weekly collected and anti-BSA IgG
levels were quantified by ELISA immunoassay. In the graphic, black
arrows indicate the subcutaneous BSA injections and the grey arrow
indicates the intra-articular injection. Values show the mean ± SD
(n = 4). *Statistically significant difference (p ≤ 0.05) compared to
basal level
Fig. 4 Distribution of synovial lymphocyte subsets. Synovial fluid lymphocytes were collected for flow cytometric analysis just before intra-articular
injection (basal) and 7 days after. The graphic shows the percentage of CD4+ T cells (a) CD8+ T cells (b) and their ratio c. Values show the mean ± SD
(n = 3). *Statistically significant difference (p ≤ 0.05) compared to basal level
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is based on a previous report from El-Gabalawy [19]
where synovial fluid can be classified as Normal, if it
contains fewer than 180 nucleated cells/mm3; Non-
inflammatory, when synovial fluid contains less than
2000 cells/mm3, and Inflammatory, when synovial fluid
contains 2000–50,000 cells/mm3. Our results demon-
strated that, synovial fluid from control joints can be
classified as Normal or Non-inflammatory and those syn-
ovial fluids where BSA was injected could be considered
as Inflammatory (Fig. 6e).
Monitoring of synovitis by pressure platform gait analysis
The kinematic gait parameters were evaluated by a pres-
sure platform. The pre-sensitized animals were biomech-
anically evaluated at day 7 after intra-articular injections
of BSA or PBS. The parameters evaluated were impulse
(Kg x sec) and the vertical maximum force (Kg). In
terms of animal management, our experience demon-
strated that kinematic parameters could be easily quanti-
fied with the porcine model (Fig. 7a). Our results
showed that, the impulses in the forelimbs with BSA
showed an enormous inter-individual variability (Fig. 1c)
and no significant difference was observed in terms of
vertical maximum force (Fig. 7b). Finally, it is important
to note that because of ethics and animal welfare, this
kinematic analysis had to be performed under analgesia.
Discussion
Synovitis is an inflammation of the joint lining. This in-
flammation is painful and usually linked to osteoarthritis,
rheumatoid arthritis or infections [3, 4, 6]. To alleviate
pain and discomfort, the synovitis can be successfully
treated with anti-inflammatory medications such as non-
steroidal anti-inflammatory drugs [9] or biological therap-
ies [10, 11, 14, 20]. At the present, new therapies are
currently being investigated to improve their clinical
efficacy and to reduce the adverse effects commonly asso-
ciated to non-steroidal anti-inflammatory drugs.
Clinically relevant animal models are essential to
evaluate therapeutic strategies to target inflammation
and to predict outcome of clinical trials. The anatomical
similarities between pigs and humans, particularly for
surgical procedures, makes this animal model a valuable
tool to evaluate the safety, feasibility and dosage pattern
of new therapies for synovitis. Based on that, the main
objective of our work has been focused in the develop-
ment of an experimentally-induced synovitis model to
be used for the evaluation and follow up of synovitis
from different perspectives. It is important to note that,
the synovitis in the animal is triggered by a T cell-
mediated response induced by BSA, which is somehow
comparable to the T cell-mediated response in the
synovial tissue of clinically active rheumatoid arthritis
patients [21].
It is interesting to note that immunologically induced
synovitis models have been previously described in pigs.
In this sense, Möller et al. succeeded in inducing a reli-
able and reproducible synovitis using turkey egg albumin
(more appropriate than chicken egg albumin) [18]. This
animal model was proposed to be useful to investigate
the potential applicability of laser treatment in arthro-
scopic synovectomy. In contrast to our BSA-induced
synovitis model, in the turkey egg albumin model from
Möller et al. the synovitis examination was performed in
terms of macroscopic observations (joint profile, synovial
fluid and membrane) as well as in terms of histologic find-
ings (synovial membrane, stratum synoviale and fibro-
sum). Our antigen-induced synovitis model provides the
methodologies and procedures for monitoring the inflam-
mation in terms of immune biomarkers. Moreover, simi-
larly to the model from Möller et al. this animal model
allowed us the evaluation of synovitis by arthroscopic
inspection.
First of all, the BSA pre-sensitization in the porcine
model was optimized and adapted taking as a reference
previous reports with rabbits and dogs [22–24]. Similarly
to antigen-induced synovitis model developed in other
animals, our results demonstrated that BSA emulsified
with complete Freund’s adjuvant was strongly efficient
to promote a rapid and maintained antigen-specific
humoral response. Moreover, based on the kinetic of the
Fig. 5 Quantification of IL-12p40 levels in synovial fluid. Synovial
fluid was collected at day 7, 14 and 21 after intra-articular injection
of PBS and BSA. Cytokine levels were determined by Luminex xMAP
technology. The lower boundary of the box indicates the 25th
percentile and the upper boundary the 75th percentile. Bars above
and below the box indicate the 90th and 10th percentiles. The line
within the box marks the median (n = 4). Dot line indicates the basal
levels (just before intra-articular injection). *Statistically significant
difference (p ≤ 0.05) compared to basal level
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humoral response against BSA, and taking into account
that the anti-BSA titers did not significantly increased
after second and third immunizations, it would be
interesting to evaluate in future experiments a different
pre-sensitization protocol based on a single BSA-
immunization. Apart from humoral response against
BSA, and in contrast to other studies using antigen-
induced synovitis models, here we focused our interest
on the cellular response. In this sense, we analyzed the
CD4+ and CD8+ T cell subsets on the peripheral blood
from BSA-immunized animals. Our results demon-
strated that BSA-immunization induced slight changes
(non-statistically significant) on T cell subsets. However,
the absence of significant changes would be the conse-
quence of analgesic and anti-inflammatory treatment
with buprenorphine (required by ethical guidelines)
during immunization.
Once demonstrated that the immunization protocol
triggered a humoral response against BSA, we aimed to
induce an inflammatory response in synovial tissue. Our
results demonstrated that, intra-articular administration
of BSA significantly induced changes on synovial
leukocyte counts. Moreover, the flow cytometry analysis
showed significant changes in the distribution of syn-
ovial CD4+ and CD8+ T cells. Based on that, and taking
into account that the presence of large numbers of
activated CD4+ T cells in synovial tissue is important in
the pathogenesis of chronic synovitis [25], here we sug-
gest that synovial T cell distribution could be suitable
biomarker in the evolution of synovitis.
Additionally, although the functional phenotype of
synovial CD4+ T cells could not be evaluated (because
of the limited availability of synovial lymphocytes), the
significant increase of synovial CD4+ T cells may reflect
Fig. 6 Surgical approach and arthroscopic analysis. Two weeks after intra-articular injection of PBS or BSA, an arthroscopic evaluation was performed.
Figure shows the access to the articular cavity a, the arthroscopic procedure b representative image of arthroscopy in the control joint
c and representative image of arthroscopy in the BSA-injected joint d. Synovial fluid classification according to nucleated cells/mm3
e. Synovial fluid is classified as “normal” if it contains less than 180 nucleated cells/mm3 or “non-inflammatory” when synovial fluid contains less than
2000 cells/mm3. On the contrary, when synovial fluid contains 2000–50,000 cells/mm3 it is classified as “inflammatory” [19]
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an increase of ‘type 1’ polarity (TH1) with CD4+
CD45RO+ phenotype and IFNγ expression. This assump-
tion is based on previous reports which demonstrated that
synovial CD4+ T cells from rheumatoid arthritis patients
were predominantly of ‘type 1’ polarity [26–28].
Additionally, in order to identify soluble factors to be
used as synovitis biomarker in this animal model, we
aimed to characterize a large panel of cytokines in the
synovial fluids from immunized animals. It is important
to note that, from an immunological and mechanistic
point of view, it was important to define if local
inflammatory response is dominated by a Th1 or Th2
response [29]. Based on that premise, the following
panel of cytokines was quantified: IFNα, IFNγ, IL-1b,
IL-4, IL-6, IL-8, IL-10, IL-12p40 and TNFα. Our
results showed that, probably because of the detection
limit of commercially available swine immune re-
agents, only IL-12p40 could be efficiently quantified
in the synovial fluids. The IL-12p40 is a subunit of
IL12p70 [30] which is mainly produced by monocytes,
macrophages and dendritic cells [31]. The presence of this
cytokine initiates the differentiation of Naïve CD4+ T cells
towards a Th1 response [32], so according to the observed
increase of IL-12p40, here we hypothesize that this
antigen-induced synovitis model is dominated by a local
Th1 response.
It is important to discuss the importance of synovial
biomarkers in the evaluation of the disease course and
monitoring of treatments. In this sense, several inflam-
matory cytokines have been defined as biomarkers in
patients with rheumatoid arthritis and osteoarthritis
[33]. Other authors have also identified the Cartilage
Oligometric Matric Proteinin in synovial fluid as a bio-
marker to predict the development of osteoarthritis [34].
The levels of C-terminal telopeptides of type II collagen
and hyaluronan have also been defined as potential
biomarkers of synovitis [35, 36]. Here we hypothesize
that IL-12p40 could be considered as immunological
biomarker in the evaluation of synovitis in this animal
model. Supporting this statement, similar changes have
been observed in the synovial tissue of rheumatoid
arthritis patients where increased IL-12p40 levels have
been detected [37].
Apart from the identification of immunological
biomarkers in the evaluation of disease progression, this
paper aimed to have a multi-criteria assessment in the
evaluation of synovitis. Arthroscopic evaluations and
pressure platform gait analyses were performed to have
Fig. 7 Pressure platform gait analysis. Seven days after intra-articular injection of PBS or BSA, a pressure platform gait analysis was performed to
evaluate plantar pressure distributions. a Above, a representative image of the gait analysis (LF: left forelimb; LH: left hind limb; RF: right forelimb;
RH: right hind limb) is represented. Below, the pressure of each limb is shown. The legend on the right shows the equivalence between numeric
and colorimetric values. Maximum forces b and impulses c in control and BSA-injected limbs (n = 4). The lower boundary of the box indicates
the 25th percentile and the upper boundary the 75th percentile. Bars above and below the box indicate the 90th and 10th percentiles. The line
within the box marks the median. No significant differences were found between PBS and BSA injected joints
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additional elements in the monitoring of synovitis.
Firstly, arthroscopy was found to be a simple and feas-
ible surgical technique to evaluate the synovitis in this
animal model. Additionally, the kinematic parameters
quantified in the animal model were a valuable tool to
evaluate the functional parameters (impulse and vertical
forces). This porcine model, in contrast to the sheep that
become nervous and more difficult to handle [38],
demonstrated several advantages in terms of animal
handling being particularly suitable for gait analysis.
Unfortunately, our results did not reveal any significant
difference in terms of impulse or vertical forces when
forelimbs were compared in the animal model. In this
case, the absence of differences would not necessarily
imply that the kinetic was unaffected, so we should
clarify that ethical consideration and animal welfare
guidelines forced us to perform the pressure gait analysis
in animals under analgesia.
Conclusions
Taking into consideration that the establishment of an
animal model is an absolute prerequisite in preclinical
research, this paper describes the development and
characterization of a clinically relevant porcine model of
synovitis. This antigen-induced inflammation model
triggered a cell-mediated response allowing us the
identification of immunological parameters to be used as
biomarkers in the monitoring of synovitis and newly
developed therapies. Moreover, here we demonstrated
that, our antigen-induced model of synovitis can also be
evaluated by standard arthroscopic instruments and
kinetic studies.
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